Research News
OCRA-Funded Research Uncovers New Checkpoint Mechanism, Potential New Therapeutic Target
New research from The Wistar Institute and Peter MacCallum Cancer Center has uncovered a previously unknown checkpoint mechanism for gene expression, that may open up new avenues for transcription-based targeted cancer therapies in the future…
Large Study Suggests Ovarian Cancer Screening in General Public Doesn’t Save Lives
Results from a large British clinical trial, which involved more than 200,000 post-menopausal women who were followed for more than 15 years, showed that screening average-risk, asymptomatic women for ovarian cancer does not reduce deaths from the…
Highlights: 2021 Virtual Annual Meeting of the American Association for Cancer Research (AACR)
The first part of this year’s annual meeting of the AACR was titled “Discovery Science Driving Clinical Breakthroughs” and was held virtually from April 10 to 14, 2021…
Highlights: 2021 Virtual Annual Meeting of the Society of Gynecologic Oncology (SGO)
2021 SGO Virtual Meeting Themes This year’s Society of Gynecologic Oncology annual meeting was held virtually, with most sessions held March 19 to 21, 2021…
The Overview: April 2021
Flowers are blooming all around us, people are beginning to rediscover the things that matter most, and every day, OCRA grantees are making strides in understanding even more about ovarian cancer…
New Study Highlights Importance of Mental Health Support for Ovarian Cancer Patients
Researchers at the University of Utah and Huntsman Cancer Institute found that an ovarian cancer diagnosis took a much higher mental toll on patients and survivors than initially expected at the start of the study, thus underscoring the…
Vulnerability in ARID1A-Mutant Cancer Cells Could Provide New Pathways for OCCC Treatment
OCRA grantees Dr. Rugang Zhang and Dr. Shuai Wu, both of The Wistar Institute, along with colleagues, have discovered a vulnerability in cancer cells that harbor certain genetic mutations…
The Overview: March 2021
The snow is (finally!) melting in the areas where many of us at OCRA work and live, the COVID vaccine is rolling out, and there is so much work being done to improve the lives of the ovarian cancer community … we can’t help but feel hopeful…
OCRA Awards Prizes in Ovarian Cancer Research
Each year, OCRA honors individuals doing important and notable work in the ovarian cancer field with a research prize to help propel their future discoveries. Individuals are selected by members of OCRA’s Scientific Advisory Committee. Dr…
OCRA Awards Millions in New Ovarian Cancer Research Grants
Despite the challenges of fundraising during a global pandemic, your generous support allowed us to fund 16 top scientists at 14 esteemed medical centers across the globe…
OCRA-Funded Research Provides a New Understanding of Ovarian Cancer Biology
OCRA-funded researcher Anil K. Sood, M.D., lead and senior author, and Sanghoon Lee, Ph.D…
Oral Contraceptives Tied to Lower Long-Term Ovarian Cancer Risk
A recent study, published in Cancer Research and reported in The New York Times, suggests that risk-reduction associated with oral contraceptive use can last a lifetime…